0000899243-21-049171.txt : 20211221
0000899243-21-049171.hdr.sgml : 20211221
20211221160534
ACCESSION NUMBER: 0000899243-21-049171
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211220
FILED AS OF DATE: 20211221
DATE AS OF CHANGE: 20211221
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gros David-Alexandre C
CENTRAL INDEX KEY: 0001644489
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36620
FILM NUMBER: 211509170
MAIL ADDRESS:
STREET 1: 220 MARLBOROUGH STREET
STREET 2: #6
CITY: BOSTON
STATE: MA
ZIP: 02116
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Eledon Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001404281
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 19900 MACARTHUR BLVD.
STREET 2: SUITE 550
CITY: IRVINE
STATE: CA
ZIP: 92612
BUSINESS PHONE: 949-238-8090
MAIL ADDRESS:
STREET 1: 19900 MACARTHUR BLVD.
STREET 2: SUITE 550
CITY: IRVINE
STATE: CA
ZIP: 92612
FORMER COMPANY:
FORMER CONFORMED NAME: Novus Therapeutics, Inc.
DATE OF NAME CHANGE: 20170511
FORMER COMPANY:
FORMER CONFORMED NAME: Tokai Pharmaceuticals Inc
DATE OF NAME CHANGE: 20070622
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-12-20
0
0001404281
Eledon Pharmaceuticals, Inc.
ELDN
0001644489
Gros David-Alexandre C
C/O ELEDON PHARMACEUTICALS, INC.
19900 MACARTHUR BLVD.,
IRVINE
CA
92612
1
1
0
0
Chief Executive Officer
Common Stock
2021-12-20
4
P
0
2000
4.48
A
9000
D
These shares were purchased in an open market transaction in accordance with the Issuer's trading policies.
/s/ Ryan A. Murr, as attorney-in-fact for David-Alexandre Gros
2021-12-21